本页面由Tiger Trade Technology Pte. Ltd.提供服务

LAVA Therapeutics N.V.

1.74
0.0000
成交量:- -
成交额:50.53万
市值:4,577.12万
市盈率:-2.02
高:1.74
开:1.74
低:1.74
收:1.74
52周最高:2.00
52周最低:0.8502
股本:2,630.53万
流通股本:1,022.19万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.8620
每股收益(LYR):-0.9359
净资产收益率:-101.51%
总资产收益率:-19.92%
市净率:3.61
市盈率(LYR):-1.86

数据加载中...

2025/11/21

交易所摘牌声明

Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend]
2025/11/21

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/11/21

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/11/21

重要事件披露

Form 8-K - Current report
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/07

重要事件披露

Form 8-K - Current report
2025/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/17

重要事件披露

Form 8-K - Current report
2025/10/02

重要事件披露

Form 8-K - Current report
2025/09/30

重要事件披露

Form 8-K - Current report
2025/08/14

重要事件披露

Form 8-K - Current report
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/04

重要事件披露

Form 8-K - Current report
2025/06/13

重要事件披露

Form 8-K - Current report
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/28

重要事件披露

Form 8-K - Current report
2025/02/28

重要事件披露

Form 8-K - Current report